Infectious Syndromes in the Pediatric Intensive Care Unit

Pediatric Critical Care

Volumn , Issue , 2006, Pages 1374-1393

  Dhanani, Sonny ^a   Cox, Peter N ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 51249120574     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032301808-1.50092-4     Document Type: Chapter

References (205)

1. Abrahamian FM Consequences of delayed diagnosis of Rocky Mountain spotted fever in children West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000. Ann Emerg Med 2001, 37:537.
2. Abramson JS, Givner LB Rocky Mountain spotted fever. Pediatr Infect Dis J 1999, 18:539.
3. Adams WV, Rose CD, Eppes SC, et al. Cognitive effects of Lyme disease in children: a 4 year followup study. J Rheumatol 1999, 26:1190.
4. Aiuto LT, Barone SR, Cohen PS, et al. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans. Crit Care Med 1997, 25:1079.
5. American Academy of Pediatrics Lyme disease. 2000 Red Book: Report of the Committee on Infectious Diseases 2000, American Academy of Pediatrics, Elk Grove Village, IL. L.K. Pickering (Ed.).
6. American Academy of Pediatrics Meningococcal infections. 2000 Red Book: Report of the Committee on Infectious Diseases 2000, American Academy of Pediatrics, Elk Grove Village, IL. L.K. Pickering (Ed.).
7. American Academy of Pediatrics Pneumococcal infections. 2000 Red Book: Report of the Committee on Infectious Diseases 2000, American Academy of Pediatrics, Elk Grove Village, IL. L.K. Pickering (Ed.).
8. American Academy of Pediatrics Rocky Mountain Spotted Fever. 2000 Red Book: Report of the Committee on Infectious Diseases 2000, American Academy of Pediatrics, Elk Grove Village, IL,. L.K. Pickering (Ed.).
9. American Academy of Pediatrics Severe invasive group A streptococcal infections: a subject review. Pediatrics 1998, 101:136.
10. American Academy of Pediatrics Staphylococcus aureus infection. 2000, 25:514.
11. American Academy of Pediatrics Streptococcal group A infections. 2000 Red Book: Report of the Committee on Infectious Diseases 2000, American Academy of Pediatrics, Elk Grove Village, IL. L.K. Pickering (Ed.).
12. American Academy of Pediatrics Tuberculosis. 2000 Red Book: Report of the Committee on Infectious Diseases 2000, American Academy of Pediatrics, Elk Grove Village, IL. L.K. Pickering (Ed.).
13. Anderson JF, Rahal JJ Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002, 8:107.
14. Andrews MM Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment. Clin Infect Dis 2001, 32:1470.
15. Anonymous New York Department of Health: West Nile virus surveillance and control: an update for healthcare providers in New York City. City Health Information 2001, 20.
16. Anonymous Haemorrhagic fever with renal syndrome; memorandum from a WHO meeting. Bull World Health Organ 1993, 61:269.
17. Antoniadis A, Le Duc JW, Daniel-Alexiou S Clinical and epidemiological aspects of hemorrhagic fever with renal syndrome (HFRS) in Greece. Eur J Epidemiol 1987, 3:295.
18. Apicella MA Neisseria meningitidis. Mandell: principles and practice of infectious diseases 2000, Churchill Livingstone, New York. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
19. Bachman DT, Srivastava G Emergency department presentations of Lyme disease in children. Pediatr Emerg Care 1998, 14:356.
20. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Ann Emerg Med 1993, 22:1198.
21. Barry W, Hudgins L, Donta ST, et al. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 1992, 267:3315.
22. Best C, Walsh J, Sinclair J, et al. Early haemo-diafiltration in meningococcal septicaemia. Lancet 1996, 347:202.
23. Bingham PM, Galetta SL, Athreya B, et al. Neurologic manifestations in children with Lyme disease. Pediatrics 1995, 96:1053.
24. Bisno AL, Stevens DL Streptococcal infections of skin and soft tissues. N Engl J Med 1996, 334:240.
25. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994, 271:665.
26. Bloom BJ, Wyckoff PM, Meissner HC, et al. Neurocognitive abnormalities in children after classic manifestations of Lyme disease. Pediatr Infect Dis J 1998, 17:189.
27. Boucek MM, Boerth RC, Artman M, et al. Myocardial dysfunction in children with acute meningococcemia. J Pediatr 1984, 105:538.
28. Brandtzaeg P, Halstensen A, Kierulf P, et al. Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microb Pathog 1992, 13:423.
29. Brandtzaeg P, Mollnes TE, Kierulf P Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis 1989, 160:58.
30. Braun M Pediatric tuberculosis, bacilli Calmette-Guerin immunization and acquired immunodeficiency syndrome. Semin Infect Dis 1993, 4:261.
31. Braunstein H Characteristics of group A streptococcal bacteremia in patients at the San Bernardino County Medical Center. Rev Infect Dis 1991, 13:8.
32. Breiman RF, Spika JS, Navarro VJ, et al. Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch Intern Med 1990, 150:1401.
33. Broome CV Epidemiology of toxic shock syndrome in the United States: overview. Rev Infect Dis 1989, 11(suppl 1):S14.
34. Buckingham SC Rocky Mountain spotted fever: a review for the pediatrician. Pediatr Ann 2002, 31:163.
35. Bujak DI, Weinstein A, Dornbush RL Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 1996, 23:1392.
36. Burman LA, Norrby R, Trollfors B Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985, 7:133.
37. Campbell GL, Marfin AA, Lanciotti RS, et al. West Nile virus. Lancet Infect Dis 2002, 2:519.
38. Carcillo JA, Davis AL, Zaritsky A Role of early fluid resuscitation in pediatric septic shock. JAMA 1991, 266:1242.
39. Cartwright K, Strang J, Gossain S, et al. Early treatment of meningococcal disease. BMJ 1992, 305:774.
40. Catterall JR Streptococcus pneumoniae. Thorax 1999, 54:929.
41. Centers for Disease Control and Prevention Consequences of delayed diagnosis of Rocky Mountain Spotted fever in children-West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000. JAMA 2000, 284:2049.
42. Centers for Disease Control and Prevention: Active Bacterial Core Surveillance (ABCs) Report, Emerging Infections Program Network (EIP), Streptococcus pneumoniae, 1998. Available at. Last accessed 1999. http://www.cdc.gov.
43. Centers for Disease Control and Prevention Core curriculum on tuberculosis: what a clinician should know 2000, US Department of Health and Human Services, Atlanta. ed 4.
44. Centers for Disease Control and Prevention Epidemiologic notes and reports toxic-shock syndrome-United States. MMWR 1997, 46:492.
45. Centers for Disease Control and Prevention Hantavirus pulmonary syndrome-United States: updated recommendations for risk reduction. MMWR 2002, 51:1.
46. Centers for Disease Control and Prevention Hantavirus pulmonary syndrome-northeastern United States 1994. MMWR 1994, 43:548.
47. Centers for Disease Control and Prevention Lyme disease-United States, 2000. MMWR 2002, 51:29.
48. Centers for Disease Control and Prevention National action plan to combat multidrug-resistant tuberculosis. MMWR 1992, 41:5.
49. Centers for Disease Control and Prevention Outbreak of West Nile-like viral encephalitis-New York, 1999. MMWR 1999, 48:849.
50. Centers for Disease Control and Prevention Prevention and control of meningococcal disease. MMWR 2000, 49:1.
51. Centers for Disease Control and Prevention Recommendations for test performance and interpretation from the second National Conference on Serologic Diagnosis of Lyme Disease. MMWR 1995, 44:590.
52. Centers for Disease Control and Prevention Reduced incidence of menstrual toxic-shock syndrome: United States, 1980-1990. MMWR 1990, 39:421.
53. Centers for Disease Control and Prevention: Reported tuberculosis in the United States, 1998. Available at. Last accessed 1999. http://www.cdc.gov.
54. Centers for Disease Control and Prevention Serosurveys for West Nile virus infection New York and Connecticut counties, 2000. MMWR 2001, 50:39.
55. Centers for Disease Control and Prevention Surveillance for Lyme disease-United States, 1992-1998. MMWR 2000, 49:1.
56. Centers for Disease Control and Prevention West Nile virus activity-United States, 2001. MMWR 2002, 51:497.
57. Chesney PJ, Davis JP, Purdy WK, et al. Clinical manifestations of toxic shock syndrome. JAMA 1981, 246:741.
58. Chesney RW, McCarron DM, Haddad JG, et al. Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. J Lab Clin Med 1983, 101:576.
59. Cobcroft R, Henderson A, Solano C, et al. Meningococcal purpura fulminans treated with antithrombin III concentrate: what is the optimal replacement therapy?. Aust N Z J Med 1994, 24:575.
60. Conlon PJ, Procop GW, Fowler V, et al. Predictors of prognosis and risk of acute renal failure in patients with Rocky Mountain spotted fever. Am J Med 1996, 101:621.
61. Cremer R, Leclerc F, Jude B, et al. Are there specific haemostatic abnormalities in children surviving septic shock with purpura and having skin necrosis or limb ischaemia that need skin grafts or limb amputations?. Eur J Pediatr 1999, 158:127.
62. Cunningham JD, Silver L, Rudikoff D Necrotizing fasciitis: a plea for early diagnosis and treatment. Mt Sinai J Med 2001, 68:253.
63. Dalton MJ, Clarke MJ, Holman RC, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995, 52:405.
64. Davies HD, Matlow A, Scriver SR, et al. Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. Pediatr Infect Dis J 1994, 13:49.
65. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996, 335:547.
66. Davis JP, Chesney PJ, Wand PJ, et al. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 1980, 303:1429.
67. Deeks SL, Palacio R, Ruvinsky R, et al. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics 1999, 103:409.
68. Demers B, Simor AE, Vellend H, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993, 16:792.
69. Derkx B, Wittes J, McCloskey R Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. Clin Infect Dis 1999, 28:770.
70. Dinerman H, Steere AC Lyme disease associated with fibromyalgia. Ann Intern Med 1992, 117:281.
71. Doctor A, Harper MB, Fleisher GR Group A beta-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Pediatrics 1995, 96(3 pt 1):428.
72. Doern GV, Heilmann KP, Huynh HK, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001, 45:1721.
73. Dooley DP, Carpenter JL, Rademacher S Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997, 25:872.
74. Doyle MG, Morrow AL, Van R, et al. Intermediate resistance of Streptococcus pneumoniae to penicillin in children in day-care centers. Pediatr Infect Dis J 1992, 11:831.
75. Drapkin MS, Wisch JS, Gelfand JA, et al. Plasmapheresis for fulminant meningococcemia. Pediatr Infect Dis J 1989, 8:399.
76. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease, The Hantavirus Study Group. N Engl J Med 1994, 330:949.
77. Editorial Acute respiratory infections in under-fives: 15 million deaths a year. Lancet 1985, ii:699.
78. Elliott DC, Kufera JA, Myers RA Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 1996, 224:672.
79. Friedland IR Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J 1995, 14:885.
80. Garlund B, Sjolin J, Nilsson A, et al. Plasma levels of cytokines in primary septic shock in humans: correlations with disease severity. J Infect Dis 1995, 172:296.
81. Gerber MA, Shapiro ED, Burke GS, et al. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 1996, 335:1270.
82. Gerber MA, Shapiro ED Diagnosis of Lyme disease in children. J Pediatr 1992, 121:157.
83. Gerber MA, Zemel LS, Shapiro ED Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics 1998, 102(4 pt 1):905.
84. Girgis NI, Farid Z, Kilpatrick ME, et al. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J 1991, 10:179.
85. Giroir BP, Quint PA, Barton P, et al. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet 1997, 350:1439.
86. Goodman JL, Bradley JF, Ross AE, et al. Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med 1995, 99:6.
87. Gurkan F, Bosnak M, Dikici B, et al. Miliary tuberculosis in children: a clinical review. Scand J Infect Dis 1998, 30:359.
88. Harrison LH, Pass MA, Mendelsohn AB, et al. Invasive meningococcal disease in adolescents and young adults. JAMA 2001, 286:694.
89. Hattwick MA, Retailliau H, O'Brien RJ, et al. Fatal Rocky Mountain spotted fever. JAMA 1978, 240:1499.
90. Haynes RE, Sanders DY, Cramblett HG Rocky Mountain spotted fever in children. J Pediatr 1970, 76:685.
91. Health Canada: West Nile virus surveillance 2002;2002: Canada. Infectious diseases news brief. Centre for Infectious Disease Prevention and Control, Population and Public Health Branch.
92. Helmick CG, Bernard KW, D'Angelo LJ Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 1984, 150:480.
93. Henriques NB, Novak R, Ortqvist A, et al. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis 2001, 32:552.
94. Hodes DS, Barzilai A Invasive and toxin-mediated Staphylococcus aureus diseases in children. Adv Pediatr Infect Dis 1990, 5:35.
95. Hoge CW, Schwartz B, Talkington DF, et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: A retrospective population-based study. JAMA 1993, 269:384.
96. Holden M, Dubin MR, Diamond PH Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 1971, 285:1506.
97. Hsu KK, Starke JR Diagnosis and treatment of tuberculosis infection. Semin Pediatr Infect Dis 1993, 4:283.
98. Hubalek Z Comparative symptomatology of West Nile fever. Lancet 2001, 358:254.
99. Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991, 164:1119.
100. Hughes C Rocky Mountain 'spotless' fever with an erythema migrans-like skin lesion. Clin Infect Dis 1995, 21:1328.
101. J5 Sudy Group Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J Infect Dis 1992, 165:695.
102. Jarrett P, Rademaker M, Duffill M The clinical spectrum of necrotising fasciitis: a review of 15 cases. Aust N Z J Med 1997, 27:29.
103. Kain KC, Schulzer M, Chow AW Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses. Clin Infect Dis 1993, 16:100.
104. Kaplan SL, Mason EO, Barson WJ, et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics 1998, 102(3 pt 1):538.
105. Kaplan SL, Mason EO Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002. Pediatr Ann 2002, 31:250.
106. Khan AS, Khabbaz RF, Armstrong LR, et al. Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis 1996, 173:1297.
107. Khan AS, Ksiazek TG, Peters CJ Hantavirus pulmonary syndrome. Lancet 1996, 347:739.
108. Kim PE, Musher DM, Glezen WP, et al. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis 1996, 22:100.
109. Kirk JL, Fine DP, Sexton DJ, et al. Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986. Medicine (Baltimore) 1990, 69:35.
110. Kirkland KB, Marcom PK, Sexton DJ, et al. Rocky Mountain spotted fever complicated by gangrene: report of six cases and review. Clin Infect Dis 1993, 16:629.
111. Kirkland KB, Wilkinson WE, Sexton DJ Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995, 20:1118.
112. Kirsch EA, Barton RP, Kitchen L, et al. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J 1996, 15:967.
113. Kuppermann N, Inkelis SH, Saladino R The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans. Pediatr Infect Dis J 1994, 13:867.
114. Lamothe F, D'Amico P, Ghosn P, et al. Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review. Clin Infect Dis 1995, 21:1469.
115. Leclerc F, Leteurtre S, Cremer R, et al. Do new strategies in meningococcemia produce better outcomes?. Crit Care Med 2000, 28(9 Suppl):S60.
116. Levin M, Galassini R, de Munter C et al: Improved survival in children admitted to intensive care with meningococcal disease. 1998.
117. Levine DP, Fromm BS, Reddy BR Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991, 115:674.
118. Lockary ME, Lockhard PB, Williams JT Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 1998, 17:429.
119. Logigian EL, Kaplan RF, Steere AC Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990, 323:1438.
120. Lowy FD Staphylococcus aureus infections. N Engl J Med 1998, 339:520.
121. Mahmoudi A, Iseman MD Pitfalls in the care of patients with tuberculosis: Common errors and their association with the acquisition of drug resistance. JAMA 1993, 270:65.
122. Malley R, Ambrosino D Pneumococcal diseases in children: morbidity, mortality, and resistance. University of Chicago Children's Hospital Reports on Current Concepts in the Use of Pediatric Vaccines. 1998, 1:1.
123. Marfin AA, Gubler DJ West Nile encephalitis: an emerging disease in the United States. Clin Infect Dis 2001, 33:1713.
124. Marzouk O, Thomson AP, Sills JA, et al. Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child 1991, 66:485.
125. McCracken GH Diagnosis and management of pneumonia in children. Pediatr Infect Dis J 2000, 19:924.
126. McCracken GH Etiology and treatment of pneumonia. Pediatr Infect Dis J 2000, 19:373.
127. McKenna MT, McCray E, Onorato I The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med 1995, 332:1071.
128. Mcmaster P, Shann F The use of extracorporeal techniques to remove humoral factors in sepsis. Pediatr Crit Care Med 2003, 4:2.
129. Meek J West Nile virus in the United States. Curr Opin Pediatr 2002, 14:72.
130. Melish ME, Murata S, Fukunaga C, et al. Endotoxin is not an essential mediator in toxic shock syndrome. Rev Infect Dis 1989, 11(suppl 1):S219.
131. Mufson MA, Stanek RJ Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997. Am J Med 1999, 107(1A):34S.
132. Musher DM Pneumococcus. Mandell: principles and practice of infectious diseases 2000, Churchill Livingstone, New York. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
133. Nadel S, Britto J, Booy R, et al. Avoidable deficiencies in the delivery of health care to children with meningococcal disease. J Accid Emerg Med 1998, 15:298.
134. Nadel S, Levin M, Habibi P Treatment of meningococcal disease in childhood. Meningoccal disease 1995, John Wiley and Sons, Chichester. K. Cartwright (Ed.).
135. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001, 344:1807.
136. Nemir RL, O'Hare D Tuberculosis in children 10 years of age and younger: three decades of experience during the chemotherapeutic era. Pediatrics 1991, 88:236.
137. Newcombe J, Dyer S, Blackman L, et al. PCR-single-stranded confirmational polymorphism analysis for non-culture-based subtyping of meningococcal strains in clinical specimens. J Clin Microbiol 1997, 35:1809.
138. Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993, 262:914.
139. Nocton JJ, Dressler F, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994, 330:229.
140. O'Brien KL, Levine OS, Schwartz B The changing epidemiology of group A streptococcus infections. Semin Pediar Infect Dis 1997, 8:1.
141. Oschmann P, Dorndorf W, Hornig C, et al. Stages and syndromes of neuroborreliosis. J Neurol 1998, 245:262.
142. Ostrov BE, Athreya BH Lyme disease: Difficulties in diagnosis and management. Pediatr Clin North Am 1991, 38:535.
143. Peter G The child with pneumonia: diagnostic and therapeutic considerations. Pediatr Infect Dis J 1988, 7:453.
144. Petersen LR, Marfin AA West Nile virus: a primer for the clinician. Ann Intern Med 2002, 137:173.
145. Petersen LR, Roehrig JT West Nile virus: a reemerging global pathogen. Emerg Infect Dis 2001, 7:611.
146. Pini NC, Resa A, del Jesus LG, et al. Hantavirus infection in children in Argentina. Emerg Infect Dis 1998, 4:85.
147. Pollack MM, Alexander SR, Clarke N, et al. Improved outcomes from tertiary center pediatric intensive care: a statewide comparison of tertiary and nontertiary care facilities. Crit Care Med 1991, 19:150.
148. Pollard AJ, Britto J, Nadel S, et al. Emergency management of meningococcal disease. Arch Dis Child 1999, 80:290.
149. Pollard AJ, DeMunter C, Nadel S, et al. Abandoning empirical antibiotics for febrile children. Lancet 1997, 350:811.
150. Pollard AJ, Moxon ER The meningococcus tamed?. Arch Dis Child 2002, 87:13.
151. Pomputius WF, Rost J, Dennehy PH, et al. Standardization of gastric aspirate technique improves yield in the diagnosis of tuberculosis in children. Pediatr Infect Dis J 1997, 16:222.
152. Procop GW, Burchette JL, Howell DN, et al. Immunoperoxidase and immunofluorescent staining of Rickettsia rickettsii in skin biopsies: a comparative study. Arch Pathol Lab Med 1997, 121:894.
153. Qureshi MZ, New D, Zulqarni NJ, et al. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J 2002, 21:12.
154. Reeves JH, Butt WW Blood filtration in children with severe sepsis: safe adjunctive therapy. Intensive Care Med 1995, 21:500.
155. Rivard GE, David M, Farrell C, et al. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 1995, 126:646.
156. Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001, 285:1729.
157. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999, 180:1894.
158. Salazar JC, Gerber MA, Goff CW Long-term outcome of Lyme disease in children given early treatment. J Pediatr 1993, 122:591.
159. Schlievert PM, Assimacopoulos AP, Cleary PP Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin Med 1996, 127:13.
160. Schlievert PM Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J Allergy Clin Immunol 2001, 108(4 suppl):S107.
161. Seltzer EG, Gerber MA, Cartter ML, et al. Long-term outcomes of persons with Lyme disease. JAMA 2000, 283:609.
162. Seltzer EG, Shapiro ED, Gerber MA Long-term outcomes of Lyme disease. JAMA 2000, 283:3068.
163. Sexton DJ, Kaye KS Rocky mountain spotted fever. Med Clin North Am 2002, 86:351.
164. Shimoni Z, Niven MJ, Pitlick S, et al. Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis 2001, 7:759.
165. Smith KC, Starke JR, Eisenach K, et al. Detection of Mycobacterium tuberculosis in clinical specimens from children using a polymerase chain reaction. Pediatrics 1996, 97:155.
166. Smith KC Tuberculosis in children. Curr Probl Pediatr 2001, 31:1.
167. Smithburn KC, Hughes TP, Burke AW, et al. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 1940, 20:471.
168. Sood SK Lyme disease. Pediatr Infect Dis J 1999, 18:913.
169. Starke JR Tuberculosis of the central nervous system in children. Semin Pediatr Neurol 1999, 6:318.
170. Steere AC Lyme disease. N Engl J Med 1989, 321:586.
171. Steere AC Lyme disease. N Engl J Med 2001, 345:115.
172. Stevens DL, Bryant AE, Hackett SP Antibiotic effects on bacterial viability, toxin production, and host response. Clin Infect Dis 1995, 20(suppl 2):S154.
173. Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988, 158:23.
174. Stevens DL Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?. Clin Infect Dis 1995, 21:977.
175. Stevens DL Invasive group A streptococcal infections: the past, present and future. Pediatr Infect Dis J 1994, 13:561.
176. Stevens DL Invasive group A streptococcus infections. Clin Infect Dis 1992, 14:2.
177. Stevens DL Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995, 1:69.
178. Sumaya CV, Simek M, Smith MH, et al. Tuberculous meningitis in children during the isoniazid era. J Pediatr 1975, 87:43.
179. Szer IS, Taylor E, Steere AC The long-term course of Lyme arthritis in children. N Engl J Med 1991, 325:159.
180. Takei S, Arora YK, Walker SM Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993, 91:602.
181. Tan TQ, Mason EO, Barson WJ, et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics 1998, 102:1369.
182. Tan TQ Pneumococcal infections in children. Pediatr Ann 2002, 31:241.
183. Taylor JP, Tanner WB, Rawlings JA, et al. Serological evidence of subclinical Rocky Mountain spotted fever infections in Texas. J Infect Dis 1985, 151:367.
184. The Working Group on Severe Streptococcal Infections Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993, 269:390.
185. Thomson AP, Sills JA, Hart CA Validation of the Glasgow meningococcal septicemia prognostic score: a 10-year retrospective survey. Crit Care Med 1991, 19:26.
186. Thorburn K, Baines P, Thomson A, et al. Mortality in severe meningococcal disease. Arch Dis Child 2001, 85:382.
187. Thorner AR, Walker DH, Petri WA Rocky mountain spotted fever. Clin Infect Dis 1998, 27:1353.
188. Tibbles PM, Edelsberg JS Hyperbaric-oxygen therapy. N Engl J Med 1996, 334:1642.
189. Tikhomirov E, Santamaria M, Esteves K Meningococcal disease: public health burden and control. World Health Stat Q 1997, 50:170.
190. Todd JK, Ressman M, Caston SA, et al. Corticosteroid therapy for patients with toxic shock syndrome. JAMA 1984, 252:3399.
191. Treadwell TA, Holman RC, Clarke MJ, et al. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg 2000, 63:21.
192. Vallejo JG, Ong LT, Starke JR Clinical features, diagnosis, and treatment of tuberculosis in infants. Pediatrics 1994, 94:1.
193. Waldvogal FA Staphylococcus aureus. Mandell: principles and practice of infectious diseases 2000, Churchill Livingstone, New York. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
194. Walker DH, Lane TW Rocky Mountain spotted fever: clinical signs, symptoms, and pathophysiology. Biology of rickettsial diseases 1998, CRC Press, Boca Raton. D.H. Walker (Ed.).
195. Walker DH, Matern WD Rickettsial vasculitis. Am Heart J 1980, 100:896.
196. Walker DH, Raoult D Rickettsia rickettsii and other spotted fever group rickettsiae (Rocky Mountain spotted fever and other spotted fevers). Mandell: principles and practice of infectious diseases 2000, Churchill Livingstone, New York. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
197. Wang JF, Caugant DA, Li X, et al. Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun 1992, 60:5267.
198. Wang TJ, Sangha O, Phillips CB, et al. Outcomes of children treated for Lyme disease. J Rheumatol 1998, 25:2249.
199. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001, 7:654.
200. Williams CL, Strobino B, Lee A, et al. Lyme disease in childhood: clinical and epidemiologic features of ninety cases. Pediatr Infect Dis J 1990, 9:10.
201. Wilson GJ, Talkington DF, Gruber W, et al. Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. Clin Infect Dis 1995, 20:1333.
202. Woolf PK, Lorsung EM, Edwards KS, et al. Electrocardiographic findings in children with Lyme disease. Pediatr Emerg Care 1991, 7:334.
203. World Health Organization Groups at risk: WHO report on the tuberculosis epidemic. 1996 1996, World Health Organization, Geneva.
204. Zangwill KM, Vadheim CM, Vannier AM, et al. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996, 174:752.
205. Zittergruen M, Grose C Magnetic resonance imaging for early diagnosis of necrotizing fasciitis. Pediatr Emerg Care 1993, 9:26.